Yahoo
NYSE - Delayed Quote USD

Prestige Consumer Healthcare Inc. (PBH)

47.79 +0.40 (+0.84%)
At close: October 28 at 4:00:02 PM EDT
48.04 +0.25 (+0.52%)
Pre-Market: 4:00:20 AM EDT
Trade PBH on Coinbase
Chart Range Bar
Loading chart for PBH
  • Previous Close 47.39
  • Open 46.84
  • Bid --
  • Ask --
  • Day's Range 46.63 - 48.13
  • 52 Week Range 42.62 - 71.07
  • Volume 504,884
  • Avg. Volume 564,342
  • Market Cap (intraday) 2.264B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 13.39
  • EPS (TTM) 3.57
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 67.80
  • Morningstar Rating Rating available with Stock Picks access

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

www.prestigebrands.com

890

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PBH
22.53%
S&P 500 (^GSPC)
13.13%

1-Year Return

PBH
22.96%
S&P 500 (^GSPC)
12.38%

3-Year Return

PBH
18.79%
S&P 500 (^GSPC)
88.08%

5-Year Return

PBH
20.04%
S&P 500 (^GSPC)
68.48%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 265.71M
Earnings 29.18M
Profit Margin 10.98%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
100M
200M
12.0%
14.0%
16.0%
18.0%

Analyst Insights

View More

Analyst Price Targets

55.00
67.80 Average
47.79 Current
75.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/15/2026
Analyst Canaccord Genuity
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 86 -> 72

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.57%

  • Return on Assets (ttm)

    4.58%

  • Return on Equity (ttm)

    9.12%

  • Revenue (ttm)

    1.1B

  • Net Income Avi to Common (ttm)

    172.01M

  • Diluted EPS (ttm)

    3.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    89.13M

  • Total Debt/Equity (mrq)

    107.86%

  • Levered Free Cash Flow (ttm)

    147.89M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: